Asian efforts in AIDS vaccine development step up
21-Sep-2010 - Regional efforts towards an AIDS vaccine must be strengthened and harmonized, says a new article in this
week's PLoS Medicine Magazine. Yiming Shao from the National Center for AIDS/STD Control and Prevention in Beijing, China and colleagues
from a range of Asian and international agencies announce the formation of AVAN-the AIDS Vaccine for Asia Network-that aims to strengthen its
regional efforts in finding an AIDS vaccine.
The authors say that AVAN has been set up to help facilitate the development of a regional AIDS vaccine strategy that
will: accelerate research and development of an AIDS vaccine through government advocacy, improved coordination and harmonization of
research; develop clinical trial and manufacturing capacity; support ethical and regulatory frameworks; and ensure community participation.
More than 5 million people have already been infected with HIV across Asia, and another 500 million are considered
at risk, say the authors.
Funding:No specific funding was received for this article.
Competing Interests: The authors have declared that no competing interests exist.
Citation: Kent SJ, Cooper DA, Chhi Vun M, Shao Y, Zhang L, et al. (2010) AIDS Vaccine for Asia Network (AVAN): Expanding the Regional
Role in Developing HIV Vaccines. PLoS Med 7(9): e1000331. doi:10.1371/journal.pmed.1000331
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000331
PRESS-ONLY PREVIEW OF THE ARTICLE: www.plos.org/press/plme-07-09-shao.pdf
155 Changbai Road
Beijing, Beijing 102206
010 58900980 (fax)
Contact: Katie Hickling
Public Library of Science